Where does Medigene Immunotherapies Gmbh rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medigene Immunotherapies Gmbh ranks #22,962 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medigene Immunotherapies Gmbh hold?

Medigene Immunotherapies Gmbh holds 12 US utility patents granted between 2020 and 2025, spanning 6 technology areas.

What is Medigene Immunotherapies Gmbh's Innovation Score?

Medigene Immunotherapies Gmbh has an Innovation Score of 38.5 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medigene Immunotherapies Gmbh focus on?

Medigene Immunotherapies Gmbh's top technology area is C07K (PEPTIDES) with 12 patents. Grants appear in 6 CPC subclasses total.

Is Medigene Immunotherapies Gmbh's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Medigene Immunotherapies Gmbh.

What does claim depth mean for Medigene Immunotherapies Gmbh's patents?

Medigene Immunotherapies Gmbh's patents average 16.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medigene Immunotherapies Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medigene Immunotherapies Gmbh

USPTO PatentsView assignee record - 12 granted patents across 6 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (PEPTIDES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medigene ranks #22,962 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 6 technology areas.

#22,962
of 50,000 US assignees by volume: Top 40%
by Innovation Score (38.5/100): 16.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R22962 · Foreign Corporation #22,962 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 12 grants
MID-PACK #22,962/50,000
PHOTO-FINISH MATERION NEWTON
CPC-NARROW C07K · 6 areas
INNOV-THIN 38.5/100
CLAIMS-RICH 16.5 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Materion Newton Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Medigene Immunothera… · this assignee

39
Nidec-shimpo · near

39
Nocira · near

39
Phoenix Contact E-mo… · near

39
Quick Fitting Holding · near

39
3D Lighting Innovati… · lowest

7

What this shows Medigene's Innovation Score is 38.5/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Medigene's grants concentrate

Medigene Immunotherapies Gmbh is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C07K (PEPTIDES). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2020. By volume, Medigene sits between Materion Newton Inc. and Melitta Single Portions Gmbh & Co. KG.

Materion Newton

12
Maxlinear ASIA Si…

12
Media IP

12
Medical Microinst…

12
Medipost

12
Meiji University

12
Meissner Filtrati…

12
Melitta Single Po…

12
Medigene Immunoth… ◀

12

What this shows Medigene holds 12 patents at rank #22,935, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medigene

By rank, the assignees closest to #22,935 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Medigene's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medigene, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Nocira, Llc 39 Nidec-shimpo Corporation 39 Quick Fitting Holding Company, Llc 39 Phoenix Contact E-mobility Gmbh 39

Medigene's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Medigene Immunotherapies Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	8.3%
2021	2	16.7%
2022	2	16.7%
2023	1	8.3%
2024	2	16.7%
2025partial year	4	33.3%

Which technologies does Medigene Immunotherapies Gmbh patent most?

C07K - PEPTIDES 12

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 8

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 7

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 5

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#22,962

of 50,000 tracked assignees

Innovation Score

38.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.